Craig-Hallum initiates Prenetics Global at Buy, $40 target
Craig-Hallum initiated coverage of Prenetics Global with a Buy rating and a $40.00 per-share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.